– | Discuss previous knee surgery, as well as joint disabilities |
– | Discuss frequency of bleeding episodes, response to treatment of bleeds |
– | Discuss available therapies and how they can best be used |
– | Consider inhibitor eradication strategies |
– | Disease overview |
– | Patient education regarding situations in which factor administration may be necessary, and appropriate dosing, ability to self-infuse |
– | Brief discussion of potential future health care interventions and how those can be coordinated |
– | Performed an assessment on musculoskeletal and functional status, with focus on knees and elbows |
– | Discussed bleed prophylaxis based on the avoidance of specific activities |
– | Recommend PT for general strengthening of muscles and protection of joints |
– | Discussed patient concerns related to increasing disability – personal and family impact |
– | Discuss concerns about insurance coverage for increasingly costly therapies |
Cindy Leissinger, MD Professor of Medicine, Pediatrics & Pathology Chief, Section of Hematology & Medical Oncology Tulane University School of Medicine |